Branded Generics

Bad for Patients and Budgets
The CPW Board has been seriously concerned about the increasing propensity of Health Boards to direct GPs to prescribe cheaper, branded medicines in contravention of the normal requirement to prescribe the generic equivalent. We have been pressing the argument with both Government and Health Boards that adopting this practice as a cost saving measure is somewhat futile as it actually incurs greater costs for the NHS. We have been told that in England, officials at the Department of Health have been spelling out to PCT staff the folly of prescribing branded generics as they cost the NHS considerably more than ordinary generics (which is what PSNC and CPW have been saying for years) and they have issued instructions to PCTs to stop the practice. We have written to the Assembly Minister asking that she arranges for a similar directive to be issued to Health Boards in Wales.
The Minister has subsequently called for a paper detailing the patient safety issues associated with the practice and the clinical disadvantages of switching medicines that result in an adverse impact on patient outcomes.
If you have specific examples of patients who have experienced problems as a result of switching to branded medicines please provide us with details in order that they can be included in the submission. 
follow us:
facebook twitter
Pharmacy Service Finder
Site Map | Privacy Statement | Designed by Synergy Creative | Developed by Solsoft